文献速递精神分裂症与精神病性障碍

精神分裂症综述:从神经环路机制到治疗靶点

Schizophrenia-An Overview.
PubMed 文献 · JAMA Psychiatry · 2020-01-01

本文是一篇教育性综述,整合临床病例,概述精神分裂症的临床特征、流行病学、遗传学、神经科学与精神药理学。文章围绕早期环境与遗传风险、皮层兴奋-抑制失衡、心理社会应激与皮层下多巴胺功能异常,以及治疗机制与不良反应四条主题展开,指出现有药物均通过阻断多巴胺D2受体起效。

要点

  • 早期环境与遗传风险可改变神经发育轨迹,并与前驱症状相关。
  • 皮层兴奋-抑制失衡被认为参与认知与阴性症状的发生。
  • 心理社会应激与皮层下多巴胺功能异常参与阳性症状的发生。

核心结论

  • 精神分裂症表现复杂、病因是多因素的,神经科学进展已识别出额叶、颞叶与中纹状体环路在阳性、阴性及认知症状中的作用。
  • 现有药物治疗均基于阻断多巴胺D2受体这一相同机制,这也与其不良反应相关。
  • 文中讨论的环路机制提示了新的潜在治疗靶点,可能对现有药物覆盖不佳的症状域有益。

研究设计与样本

  • 教育性综述,整合临床病例,概述精神分裂症的临床特征、流行病学、遗传学、神经科学与精神药理学。

主要发现

  • 早期环境与遗传风险因素可改变神经发育轨迹,使个体易患该病并促成前驱症状。
  • 皮层兴奋-抑制失衡参与认知与阴性症状的发生。
  • 心理社会应激、心理因素与皮层下多巴胺功能异常参与阳性症状的发生。

临床怎么用

  • 临床可依据神经发育与环路机制理解症状维度,并据此评估现有药物的疗效与不良反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Schizophrenia is a common, severe mental illness that most clinicians will encounter regularly during their practice. This report provides an overview of the clinical characteristics, epidemiology, genetics, neuroscience, and psychopharmacology of schizophrenia to provide a basis to understand the disorder and its treatment. This educational review is integrated with a clinical case to highlight how recent research findings can inform clinical understanding. OBSERVATIONS: The first theme considered is the role of early-life environmental and genetic risk factors in altering neurodevelopmental trajectories to predispose an individual to the disorder and leading to the development of prodromal symptoms. The second theme is the role of cortical excitatory-inhibitory imbalance in the development of the cognitive and negative symptoms of the disorder. The third theme considers the role of psychosocial stressors, psychological factors, and subcortical dopamine dysfunction in the onset of the positive symptoms of the disorder. The final theme considers the mechanisms underlying treatment for schizophrenia and common adverse effects of treatment. CONCLUSIONS AND RELEVANCE: Schizophrenia has a complex presentation with a multifactorial cause. Nevertheless, advances in neuroscience have identified roles for key circuits, particularly involving frontal, temporal, and mesostriatal brain regions, in the development of positive, negative, and cognitive symptoms. Current pharmacological treatments operate using the same mechanism, blockade of dopamine D2 receptor, which contribute to their adverse effects. However, the circuit mechanisms discussed herein identify novel potential treatment targets that may be of particular benefit in symptom domains not well served by existing medications.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. McCutcheon RA, Reis Marques T, Howes OD, et al. Schizophrenia-An Overview. JAMA Psychiatry. 2020. PMID: 31664453. doi:10.1001/jamapsychiatry.2019.3360

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。